Correlation Between INmune Bio and In8bio
Can any of the company-specific risk be diversified away by investing in both INmune Bio and In8bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INmune Bio and In8bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between INmune Bio and In8bio Inc, you can compare the effects of market volatilities on INmune Bio and In8bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INmune Bio with a short position of In8bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of INmune Bio and In8bio.
Diversification Opportunities for INmune Bio and In8bio
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between INmune and In8bio is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding INmune Bio and In8bio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on In8bio Inc and INmune Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INmune Bio are associated (or correlated) with In8bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of In8bio Inc has no effect on the direction of INmune Bio i.e., INmune Bio and In8bio go up and down completely randomly.
Pair Corralation between INmune Bio and In8bio
Given the investment horizon of 90 days INmune Bio is expected to under-perform the In8bio. But the stock apears to be less risky and, when comparing its historical volatility, INmune Bio is 1.96 times less risky than In8bio. The stock trades about -0.28 of its potential returns per unit of risk. The In8bio Inc is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 30.00 in In8bio Inc on September 3, 2024 and sell it today you would earn a total of 0.00 from holding In8bio Inc or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
INmune Bio vs. In8bio Inc
Performance |
Timeline |
INmune Bio |
In8bio Inc |
INmune Bio and In8bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with INmune Bio and In8bio
The main advantage of trading using opposite INmune Bio and In8bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INmune Bio position performs unexpectedly, In8bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in In8bio will offset losses from the drop in In8bio's long position.INmune Bio vs. Tff Pharmaceuticals | INmune Bio vs. Anebulo Pharmaceuticals | INmune Bio vs. AN2 Therapeutics | INmune Bio vs. Cue Biopharma |
In8bio vs. Reviva Pharmaceuticals Holdings | In8bio vs. Cue Biopharma | In8bio vs. Lantern Pharma | In8bio vs. Anixa Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |